Regenerative Medicine Market - Global Forecast upto 2024
Global Regenerative Medicine Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024
Overview: Regenerative medicine is an interdisciplinary field that applies life science and engineering principles for the regeneration or repair of injured/diseased tissues or organs resulting from various causes including, disease, defects, trauma and aging. The field includes the generation and use of tissue engineering, therapeutic stem cells and the production of artificial organs. It also allows scientists to grow organs or tissues in the lab and implant them in the body safely when the body fails to heal itself. Notably, it has great potential to solve the problem of organ shortage. According to the estimation of World Health Organization, there is an increasing prevalence of diabetes among adults over the age of 18 years, that has increased to 8.5% in 2014 compared to 4.5% in 1980 across the globe. As per the estimation of Arthritis Foundation, the number of people expected to be diagnosed from arthritis will be more than 78 million, by 2040.
The market for regenerative medicine is driven by increasing prevalence of neuronal disease, cancer and genetic disease, emerging application of regenerative medicine, and advancement in technology. Huge number of ongoing clinical trails and strong product pipeline are providing market growth oppurtunity. High cost of the treatment, regulatory issues and ethical issuesare hampering the market growth.
Market Analysis: The “Global Regenerative Medicine market” is estimated to witness a CAGR of 16.6% during the forecast period 2018–2024. The global market is analyzed based on three segments – Therapy, Application and regions.
Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global regenerative medicine market, followed by Europe. Asia-Pacific region is expected to have the fastest growth rate with the market growth centered at Japan, China and India. This is mainly due to increasing funding in healthcare research, rising research activities, growing patient pool, flexible regulatory environment for clinical trials, and rising healthcare expenditure.
Therapy Analysis: Immunotherapy occupied major market share of global regenerative medicine market in 2017, and is expected to remain same during the forecasted period. Increasing product approvals, emerging technological advancements in cell and gene therapy, flexible regulatory for stem cell based research, and growing awareness regarding the benefits of stem cell therapies.
Application Analysis: The market by application is segmented into cancer, central nervous system, orthopedic and musculoskeletal, diabetes, dermatology, cardiovascular and others. Among various application, dermatology occupied the largest share in 2017 and cancer segment is expected to grow at fastest rate during the forecasted period. Growing aging population, changing lifestyle, increasing disease prevalence makes cancer, the fastest growing application segment during the forecasted period.
Key Players: Allergan plc, Integra lifesciences, Mimedx Group, Inc., Medtronic plc, Organogenesis Inc., Zimmer Biomet, Acelity L.P. Inc., Nuvasive, Inc., Stryker Corporation, Japan Tissue Engineering Co., Ltd. (Fujifilm Holdings Corporation subsidiary), Osiris Therapeutics, Inc., Vericel Corporation and other predominate and niche players.
Competitive Analysis: Currently dermatology segment dominates the global regenerative medicine segment. A lot of researches are going on cancer, CNS, cardiovascular, orthopedic & musculoskeletal applications. The increasing importance of regenerative medicine has resulted in the launch of new products and also increased acquisition, approvals, funding to develop new product. For instance, in August 2017, Tissue Regenix Group plc completed the acquisition of acquisition of CellRight Technologies, an US based specialist in regenerative osteoinductive bone scaffolds. In April 2018, Roche acquired a program named Inception 5, focused on regenerative therapies for multiple sclerosis. In May 2018, Novartis received second FDA approval for Kymriah, CAR-T cell therapy for B-cell acute lymphoblastic leukemia (ALL).
Benefits: The report provides complete details about the usage and adoption rate of regenerative medicine in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
Overview: Regenerative medicine is an interdisciplinary field that applies life science and engineering principles for the regeneration or repair of injured/diseased tissues or organs resulting from various causes including, disease, defects, trauma and aging. The field includes the generation and use of tissue engineering, therapeutic stem cells and the production of artificial organs. It also allows scientists to grow organs or tissues in the lab and implant them in the body safely when the body fails to heal itself. Notably, it has great potential to solve the problem of organ shortage. According to the estimation of World Health Organization, there is an increasing prevalence of diabetes among adults over the age of 18 years, that has increased to 8.5% in 2014 compared to 4.5% in 1980 across the globe. As per the estimation of Arthritis Foundation, the number of people expected to be diagnosed from arthritis will be more than 78 million, by 2040.
The market for regenerative medicine is driven by increasing prevalence of neuronal disease, cancer and genetic disease, emerging application of regenerative medicine, and advancement in technology. Huge number of ongoing clinical trails and strong product pipeline are providing market growth oppurtunity. High cost of the treatment, regulatory issues and ethical issuesare hampering the market growth.
Market Analysis: The “Global Regenerative Medicine market” is estimated to witness a CAGR of 16.6% during the forecast period 2018–2024. The global market is analyzed based on three segments – Therapy, Application and regions.
Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global regenerative medicine market, followed by Europe. Asia-Pacific region is expected to have the fastest growth rate with the market growth centered at Japan, China and India. This is mainly due to increasing funding in healthcare research, rising research activities, growing patient pool, flexible regulatory environment for clinical trials, and rising healthcare expenditure.
Therapy Analysis: Immunotherapy occupied major market share of global regenerative medicine market in 2017, and is expected to remain same during the forecasted period. Increasing product approvals, emerging technological advancements in cell and gene therapy, flexible regulatory for stem cell based research, and growing awareness regarding the benefits of stem cell therapies.
Application Analysis: The market by application is segmented into cancer, central nervous system, orthopedic and musculoskeletal, diabetes, dermatology, cardiovascular and others. Among various application, dermatology occupied the largest share in 2017 and cancer segment is expected to grow at fastest rate during the forecasted period. Growing aging population, changing lifestyle, increasing disease prevalence makes cancer, the fastest growing application segment during the forecasted period.
Key Players: Allergan plc, Integra lifesciences, Mimedx Group, Inc., Medtronic plc, Organogenesis Inc., Zimmer Biomet, Acelity L.P. Inc., Nuvasive, Inc., Stryker Corporation, Japan Tissue Engineering Co., Ltd. (Fujifilm Holdings Corporation subsidiary), Osiris Therapeutics, Inc., Vericel Corporation and other predominate and niche players.
Competitive Analysis: Currently dermatology segment dominates the global regenerative medicine segment. A lot of researches are going on cancer, CNS, cardiovascular, orthopedic & musculoskeletal applications. The increasing importance of regenerative medicine has resulted in the launch of new products and also increased acquisition, approvals, funding to develop new product. For instance, in August 2017, Tissue Regenix Group plc completed the acquisition of acquisition of CellRight Technologies, an US based specialist in regenerative osteoinductive bone scaffolds. In April 2018, Roche acquired a program named Inception 5, focused on regenerative therapies for multiple sclerosis. In May 2018, Novartis received second FDA approval for Kymriah, CAR-T cell therapy for B-cell acute lymphoblastic leukemia (ALL).
Benefits: The report provides complete details about the usage and adoption rate of regenerative medicine in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
1 INDUSTRY OUTLOOK
1.1 Industry Overview
1.2 Total addressable market
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Advantages of regenerative medicine
3.3 Disadvantage of regenerative medicine
3.4 Segmented Addressable Market (SAM)
3.5 Trends of the regenerative medicine market
3.6 Related Markets
3.6.1 Wound Biologics
Trends of Wound Biologics market
3.6.2 Stem cell banking
Trends of stem banking market
4 MARKET OUTLOOK
4.1 Market segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 DRO – Global Regenerative Medicine Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing incidence of disease
5.1.1.2 Wide application range of regenerative medicine
5.1.1.3 Technological advancement
5.1.2 Opportunities
5.1.2.1 Huge number of ongoing clinical trails and strong portfolio of product pipelin
5.1.2.2 Increased collaboration and partnership
5.1.3 Restraints
5.1.3.1 High treatment cost
5.1.3.2 Ethical issues
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 THERAPY: MARKET SIZE & ANALYSIS
6.1 Overview
6.2 Cell therapy
6.3 Gene Therapy
6.4 Tissue Engineering
6.5 Biologics and Small molecules
7 APPLICATIONS: MARKET SIZE & ANALYSIS
7.1 Overview
7.2 Cancer
7.3 Central Nervous System (CNS)
7.4 Diabetes
7.5 Cardiovascular disease
7.6 Dermatology
7.7 Orthopedic and Musculoskeletal
7.8 Others
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 UK
8.3.2 Germany
8.3.3 France
8.3.4 Spain
8.4 Asia Pacific
8.4.1 India
8.4.2 China
8.4.3 Japan
8.5 Rest of the World
9 COMPETITIVE LANDSCAPE
9.1 Overview
10 VENDOR PROFILES
10.1 Medtronic Plc
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Organogenesis Inc
10.2.1 Overview
10.2.2 Business Focus
10.2.3 SWOT Analysis
10.2.4 Business Strategies
10.3 Integra Life Sciences Corp.
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 MiMedx Group
10.4.1 Overview
10.4.2 Business Focus
10.4.3 SWOT Analysis
10.4.4 Business Strategies
10.5 Zimmer Biomet Holdings, Inc.
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Presence
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
11 COMPANIES TO WATCH FOR
11.1 Novartis AG
11.1.1 Overview
11.2 Allergan plc
11.2.1 Overview
11.3 Vericel Corporation
11.3.1 Overview
11.4 NuVasive, Inc.
11.4.1 Overview
11.5 Vertex Pharmaceutical Incorporated
11.5.1 Overview
11.6 Acelity LP
11.6.1 Overview
11.7 Osiris Therapeutics, Inc.
11.7.1 Overview
11.7.2 Highlights
Annexure
Acronyms
1.1 Industry Overview
1.2 Total addressable market
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Advantages of regenerative medicine
3.3 Disadvantage of regenerative medicine
3.4 Segmented Addressable Market (SAM)
3.5 Trends of the regenerative medicine market
3.6 Related Markets
3.6.1 Wound Biologics
Trends of Wound Biologics market
3.6.2 Stem cell banking
Trends of stem banking market
4 MARKET OUTLOOK
4.1 Market segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 DRO – Global Regenerative Medicine Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing incidence of disease
5.1.1.2 Wide application range of regenerative medicine
5.1.1.3 Technological advancement
5.1.2 Opportunities
5.1.2.1 Huge number of ongoing clinical trails and strong portfolio of product pipelin
5.1.2.2 Increased collaboration and partnership
5.1.3 Restraints
5.1.3.1 High treatment cost
5.1.3.2 Ethical issues
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 THERAPY: MARKET SIZE & ANALYSIS
6.1 Overview
6.2 Cell therapy
6.3 Gene Therapy
6.4 Tissue Engineering
6.5 Biologics and Small molecules
7 APPLICATIONS: MARKET SIZE & ANALYSIS
7.1 Overview
7.2 Cancer
7.3 Central Nervous System (CNS)
7.4 Diabetes
7.5 Cardiovascular disease
7.6 Dermatology
7.7 Orthopedic and Musculoskeletal
7.8 Others
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 UK
8.3.2 Germany
8.3.3 France
8.3.4 Spain
8.4 Asia Pacific
8.4.1 India
8.4.2 China
8.4.3 Japan
8.5 Rest of the World
9 COMPETITIVE LANDSCAPE
9.1 Overview
10 VENDOR PROFILES
10.1 Medtronic Plc
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Organogenesis Inc
10.2.1 Overview
10.2.2 Business Focus
10.2.3 SWOT Analysis
10.2.4 Business Strategies
10.3 Integra Life Sciences Corp.
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 MiMedx Group
10.4.1 Overview
10.4.2 Business Focus
10.4.3 SWOT Analysis
10.4.4 Business Strategies
10.5 Zimmer Biomet Holdings, Inc.
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Presence
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
11 COMPANIES TO WATCH FOR
11.1 Novartis AG
11.1.1 Overview
11.2 Allergan plc
11.2.1 Overview
11.3 Vericel Corporation
11.3.1 Overview
11.4 NuVasive, Inc.
11.4.1 Overview
11.5 Vertex Pharmaceutical Incorporated
11.5.1 Overview
11.6 Acelity LP
11.6.1 Overview
11.7 Osiris Therapeutics, Inc.
11.7.1 Overview
11.7.2 Highlights
Annexure
Acronyms
LIST OF TABLES
Table 1 GLOBAL REGENERATIVE MEDICINE MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION)
Table 2 OTHER PROMINENT VENDORS OF REGENERATIVE MEDICINE MARKET
Table 3 MEDTRONIC PLC: OFFERINGS
Table 4 MEDTRONIC PLC: RECENT DEVELOPMENTS
Table 5 ORGANOGENESIS INC: OFFERINGS
Table 6 ORGANOGENESIS INC: RECENT DEVELOPMENTS
Table 7 INTEGRA LIFE SCIENCES CORP.: OFFERINGS
Table 8 INTEGRA LIFE SCIENCES CORP.: RECENT DEVELOPMENTS
Table 9 MIMEDX: OFFERINGS
Table 10 MIMEDX GROUP: RECENT DEVELOPMENTS
Table 11 ZIMMER BIOMET: OFFERINGS
Table 12 ZIMMER BIOMET HOLDINGS, INC.: RECENT DEVELOPMENTS
Table 13 NOVARTIS AG.: SNAPSHOT
Table 14 NOVARTIS AG: RECENT DEVELOPMENTS
Table 15 ALLERGAN PLC.: SNAPSHOT
Table 16 ALLERGAN PLC: RECENT DEVELOPMENTS
Table 17 VERICEL CORPORATION: SNAPSHOT
Table 18 VERICEL CORPORATION: RECENT DEVELOPMENTS
Table 19 NUVASIVE, INC.: SNAPSHOT
Table 20 NUVASIVE, INC.: RECENT DEVELOPMENTS
Table 21 VERTEX PHARMACEUTICAL INCORPORATED: SNAPSHOT
Table 22 VERTEX PHARMACEUTICAL INCORPORATED: RECENT DEVELOPMENTS
Table 23 ACELITY LP: SNAPSHOT
Table 24 ACELITY LP: RECENT DEVELOPMENTS
Table 25 OSIRIS THERAPEUTICS, INC: OVERVIEW
Table 1 GLOBAL REGENERATIVE MEDICINE MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION)
Table 2 OTHER PROMINENT VENDORS OF REGENERATIVE MEDICINE MARKET
Table 3 MEDTRONIC PLC: OFFERINGS
Table 4 MEDTRONIC PLC: RECENT DEVELOPMENTS
Table 5 ORGANOGENESIS INC: OFFERINGS
Table 6 ORGANOGENESIS INC: RECENT DEVELOPMENTS
Table 7 INTEGRA LIFE SCIENCES CORP.: OFFERINGS
Table 8 INTEGRA LIFE SCIENCES CORP.: RECENT DEVELOPMENTS
Table 9 MIMEDX: OFFERINGS
Table 10 MIMEDX GROUP: RECENT DEVELOPMENTS
Table 11 ZIMMER BIOMET: OFFERINGS
Table 12 ZIMMER BIOMET HOLDINGS, INC.: RECENT DEVELOPMENTS
Table 13 NOVARTIS AG.: SNAPSHOT
Table 14 NOVARTIS AG: RECENT DEVELOPMENTS
Table 15 ALLERGAN PLC.: SNAPSHOT
Table 16 ALLERGAN PLC: RECENT DEVELOPMENTS
Table 17 VERICEL CORPORATION: SNAPSHOT
Table 18 VERICEL CORPORATION: RECENT DEVELOPMENTS
Table 19 NUVASIVE, INC.: SNAPSHOT
Table 20 NUVASIVE, INC.: RECENT DEVELOPMENTS
Table 21 VERTEX PHARMACEUTICAL INCORPORATED: SNAPSHOT
Table 22 VERTEX PHARMACEUTICAL INCORPORATED: RECENT DEVELOPMENTS
Table 23 ACELITY LP: SNAPSHOT
Table 24 ACELITY LP: RECENT DEVELOPMENTS
Table 25 OSIRIS THERAPEUTICS, INC: OVERVIEW
LIST OF CHARTS
Chart 1 RESEARCH METHODOLOGY OF GLOBAL REGENERATIVE MEDICINE MARKET
Chart 2 GLOBAL REGENERATIVE MEDICINE MARKET REVENUE, 2017–2024 ($MILLION)
Chart 3 SEGMENTATION OF GLOBAL REGENERATIVE MEDICINE MARKET
Chart 4 PEST ANALYSIS OF GLOBAL REGENERATIVE MEDICINE MARKET
Chart 5 PORTER 5 FORCES ON GLOBAL REGENERATIVE MEDICINE MARKET
Chart 6 DRO – IMPACT ANALYSIS OF GLOBAL REGENERATIVE MEDICINE MARKET
Chart 7 KEY STAKEHOLDERS
Chart 8 GLOBAL REGENERATIVE MARKET BY THERAPY SEGMENTATION, 2017 (%)
Chart 9 GLOBAL CELL THERAPY MARKET FORECAST, 2017–2024 ($MILLION)
Chart 10 GLOBAL GENE THERAPY MARKET FORECAST, 2017–2024 ($MILLION)
Chart 11 GLOBAL TISSUE ENGINEERING MARKET FORECAST, 2017–2024 ($MILLION)
Chart 12 GLOBAL BIOLOGICS AND SMALL MOLECULES MARKET FORECAST, 2017–2024 ($MILLION)
Chart 13 GLOBAL REGENERATIVE MEDICINE MARKET BY APPLICATION SEGMENTATION, 2017 (%)
Chart 14 GLOBAL REGENERATIVE MEDICINE MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%)
Chart 15 REGENERATIVE MEDICINE MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION)
Chart 16 REGENERATIVE MEDICINE MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION)
Chart 17 REGENERATIVE MEDICINE MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION)
Chart 18 REGENERATIVE MEDICINE MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION)
Chart 19 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 20 MEDTRONIC PLC: BUSINESS UNITS
Chart 21 MEDTRONIC PLC: GEOGRAPHIC PRESENCE
Chart 22 MEDTRONIC PLC: SWOT ANALYSIS
Chart 23 ORGANOGENESIS INC: SWOT ANALYSIS
Chart 24 INTEGRA LIFE SCIENCES CORP.: OVERVIEW SNAPSHOT
Chart 25 INTEGRA LIFE SCIENCES CORP.: BUSINESS UNITS
Chart 26 INTEGRA LIFE SCIENCES CORP.: GEOGRAPHIC PRESENCE
Chart 27 INTEGRA LIFE SCIENCES CORP.: SWOT ANALYSIS
Chart 28 MIMEDX GROUP: OVERVIEW SNAPSHOT
Chart 29 MIMEDX: SWOT ANALYSIS
Chart 30 ZIMMER BIOMET HOLDINGS, INC.: OVERVIEW SNAPSHOT
Chart 31 ZIMMER BIOMET HOLDINGS, INC.: BUSINESS UNITS
Chart 32 ZIMMER BIOMET HOLDINGS, INC.: GEOGRAPHIC PRESENCE
Chart 33 ZIMMER BIOMET HOLDINGS: SWOT ANALYSIS
Chart 1 RESEARCH METHODOLOGY OF GLOBAL REGENERATIVE MEDICINE MARKET
Chart 2 GLOBAL REGENERATIVE MEDICINE MARKET REVENUE, 2017–2024 ($MILLION)
Chart 3 SEGMENTATION OF GLOBAL REGENERATIVE MEDICINE MARKET
Chart 4 PEST ANALYSIS OF GLOBAL REGENERATIVE MEDICINE MARKET
Chart 5 PORTER 5 FORCES ON GLOBAL REGENERATIVE MEDICINE MARKET
Chart 6 DRO – IMPACT ANALYSIS OF GLOBAL REGENERATIVE MEDICINE MARKET
Chart 7 KEY STAKEHOLDERS
Chart 8 GLOBAL REGENERATIVE MARKET BY THERAPY SEGMENTATION, 2017 (%)
Chart 9 GLOBAL CELL THERAPY MARKET FORECAST, 2017–2024 ($MILLION)
Chart 10 GLOBAL GENE THERAPY MARKET FORECAST, 2017–2024 ($MILLION)
Chart 11 GLOBAL TISSUE ENGINEERING MARKET FORECAST, 2017–2024 ($MILLION)
Chart 12 GLOBAL BIOLOGICS AND SMALL MOLECULES MARKET FORECAST, 2017–2024 ($MILLION)
Chart 13 GLOBAL REGENERATIVE MEDICINE MARKET BY APPLICATION SEGMENTATION, 2017 (%)
Chart 14 GLOBAL REGENERATIVE MEDICINE MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%)
Chart 15 REGENERATIVE MEDICINE MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION)
Chart 16 REGENERATIVE MEDICINE MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION)
Chart 17 REGENERATIVE MEDICINE MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION)
Chart 18 REGENERATIVE MEDICINE MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION)
Chart 19 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 20 MEDTRONIC PLC: BUSINESS UNITS
Chart 21 MEDTRONIC PLC: GEOGRAPHIC PRESENCE
Chart 22 MEDTRONIC PLC: SWOT ANALYSIS
Chart 23 ORGANOGENESIS INC: SWOT ANALYSIS
Chart 24 INTEGRA LIFE SCIENCES CORP.: OVERVIEW SNAPSHOT
Chart 25 INTEGRA LIFE SCIENCES CORP.: BUSINESS UNITS
Chart 26 INTEGRA LIFE SCIENCES CORP.: GEOGRAPHIC PRESENCE
Chart 27 INTEGRA LIFE SCIENCES CORP.: SWOT ANALYSIS
Chart 28 MIMEDX GROUP: OVERVIEW SNAPSHOT
Chart 29 MIMEDX: SWOT ANALYSIS
Chart 30 ZIMMER BIOMET HOLDINGS, INC.: OVERVIEW SNAPSHOT
Chart 31 ZIMMER BIOMET HOLDINGS, INC.: BUSINESS UNITS
Chart 32 ZIMMER BIOMET HOLDINGS, INC.: GEOGRAPHIC PRESENCE
Chart 33 ZIMMER BIOMET HOLDINGS: SWOT ANALYSIS
